|
|
FDA Medtronic Sprint Fidelis® Defibrillator Lead Recall If you or a loved one has been injured by the Medtronic Sprint Fidelis® lead, you should contact us immediately. You may be entitled to compensation and we can help. Medtronic has suspended sales of the Sprint Fidelis® family of defibrillator leads and has announced the recall of all leads not yet implanted because of the potential for lead fractures, reports of a least 5 patient deaths and other serious, life-threatening complications. The Sprint Fidelis® lead has been implanted in approximately 268,000 people worldwide. The Sprint Fidelis® lead may have also been used to connect defibrillators manufactured by other companies such as Guidant, Boston Scientific, and St. Jude. A fracture in the lead wire may result in the defibrillator either delivering an unnecessary and painful shock to the heart, or failure to deliver the necessary shock to restore proper heart rhythm. We are currently offering free consultations to patients who have been injured by heart devices or who may be suffering side-effects from a heart device. The following model numbers of the Sprint Fidelis® family of defibrillator leads have been recalled: - Sprint Fidelis® 6930
- Sprint Fidelis® 6931
- Sprint Fidelis® 6948
- Sprint Fidelis® 6949
In the circumstance where a lead “fractures,” malfunctions, or breaks, the lead may send false signals that cause inappropriate defibrillator shocks, or therapies such as pacing or shocks may not be delivered.
|